7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Celiac Disease D002446 16 associated lipids
Carotid Stenosis D016893 15 associated lipids
Periapical Granuloma D010484 3 associated lipids
HIV Infections D015658 20 associated lipids
Graves Disease D006111 6 associated lipids
Synovitis D013585 15 associated lipids
Carcinoma, Papillary D002291 3 associated lipids
Carcinoma, Non-Small-Cell Lung D002289 72 associated lipids
Arthritis, Psoriatic D015535 3 associated lipids
Atrial Fibrillation D001281 16 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Mogelvang R et al. Comparison of osteoprotegerin to traditional atherosclerotic risk factors and high-sensitivity C-reactive protein for diagnosis of atherosclerosis. 2012 Am. J. Cardiol. pmid:22100028
Tobón-Arroyave SI et al. Association of salivary levels of the bone remodelling regulators sRANKL and OPG with periodontal clinical status. 2012 J. Clin. Periodontol. pmid:23039038
Chung E and Rylander MN Response of preosteoblasts to thermal stress conditioning and osteoinductive growth factors. 2012 Cell Stress Chaperones pmid:22116637
Udomsuk L et al. Impact of Pueraria candollei var. mirifica and its potent phytoestrogen miroestrol on expression of bone-specific genes in ovariectomized mice. 2012 Fitoterapia pmid:23041523
Li J et al. Effect of oscillating fluid flow stimulation on osteocyte mRNA expression. 2012 J Biomech pmid:22119108
Xiang G et al. Change of plasma osteoprotegerin and its association with endothelial dysfunction before and after exercise in Hashimoto's thyroiditis with euthyroidism. 2012 Exp. Clin. Endocrinol. Diabetes pmid:23070830
Wang D et al. Accelerated calvarial healing in mice lacking Toll-like receptor 4. 2012 PLoS ONE pmid:23071670
Tanaka M et al. Alteration of Dickkopf-1 and receptor activator of nuclear factor-κB ligand during PBSC mobilization in healthy donors by G-CSF. 2012 Bone Marrow Transplant. pmid:22120987
Ming LG et al. [Effect of osthol on apoptosis and bone resorption of osteoclasts cultured in vitro]. 2012 Yao Xue Xue Bao pmid:22512027
Blázquez-Medela AM et al. Osteoprotegerin is associated with cardiovascular risk in hypertension and/or diabetes. 2012 Eur. J. Clin. Invest. pmid:22050177
Chaves MD et al. Bovine hydroxyapatite (Bio-Oss(®)) induces osteocalcin, RANK-L and osteoprotegerin expression in sinus lift of rabbits. 2012 J Craniomaxillofac Surg pmid:22513050
Xu S et al. Osteoprotegerin and RANKL in the pathogenesis of rheumatoid arthritis-induced osteoporosis. 2012 Rheumatol. Int. pmid:22057136
Koole D et al. Osteoprotegerin is associated with aneurysm diameter and proteolysis in abdominal aortic aneurysm disease. 2012 Arterioscler. Thromb. Vasc. Biol. pmid:22516062
Ermakov S et al. A significant association exists between receptor tyrosine kinase-like orphan receptor 2 gene variants and the OPG/RANKL ratio in human plasma. 2012 Osteoporos Int pmid:22057548
Rattazzi M et al. Osteoprotegerin levels are increased in patients with venous thromboembolic disease. 2012 J. Thromb. Haemost. pmid:22486966
Zhao X et al. hRpn13, a newly identified component of the 19S particle, regulates proliferation, differentiation, and function in the human osteoblast-like cell line MG63. [corrected]. 2012 J. Physiol. Biochem. pmid:22057889
Wang N et al. Reduced bone turnover in mice lacking the P2Y13 receptor of ADP. 2012 Mol. Endocrinol. pmid:22108801
Ozkok A et al. Osteoprotegerin/RANKL axis and progression of coronary artery calcification in hemodialysis patients. 2012 Clin J Am Soc Nephrol pmid:22490874
Funck-Brentano T et al. Targeting bone alleviates osteoarthritis in osteopenic mice and modulates cartilage catabolism. 2012 PLoS ONE pmid:22432033
Ford ML et al. FGF-23 and osteoprotegerin are independently associated with myocardial damage in chronic kidney disease stages 3 and 4. Another link between chronic kidney disease-mineral bone disorder and the heart. 2012 Nephrol. Dial. Transplant. pmid:21750158
Motovska Z et al. Circulating osteoprotegerin and Dickkopf-1 changed significantly after surgical aortic valve replacement but remained without any significant differences after transcatheter aortic valve implantation. 2012 Int. J. Cardiol. pmid:22592030
Xie H et al. Omentin-1 exerts bone-sparing effect in ovariectomized mice. 2012 Osteoporos Int pmid:21755404
Güncü GN et al. Effect of inflammation on cytokine levels and bone remodelling markers in peri-implant sulcus fluid: a preliminary report. 2012 Cytokine pmid:22592038
Helo S et al. Role of denosumab in prostate cancer. 2012 Prostate Cancer Prostatic Dis. pmid:22370723
Røysland R et al. Osteoprotegerin and cardiovascular mortality in patients with non-ST elevation acute coronary syndromes. 2012 Heart pmid:22373720
Brambila-Tapia AJ et al. MTHFR C677T, MTHFR A1298C, and OPG A163G polymorphisms in Mexican patients with rheumatoid arthritis and osteoporosis. 2012 Dis. Markers pmid:22377704
Gimenez-Maitre A et al. Deficit of osteoprotegerin release by osteoblasts from a patient with cystic fibrosis. 2012 Eur. Respir. J. pmid:22379154
Mao X et al. Protection against titanium particle-induced inflammatory osteolysis by the proteasome inhibitor bortezomib in vivo. 2012 Inflammation pmid:22391745
Kim H et al. Association between endometriosis and polymorphisms in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), TRAIL receptor and osteoprotegerin genes and their serum levels. 2012 Arch. Gynecol. Obstet. pmid:22392486
Liu S et al. Effect of simvastatin on the osteogenetic behavior of alveolar osteoblasts and periodontal ligament cells. 2012 Hum. Cell pmid:22399266
Renno AC et al. Ultrasound therapy modulates osteocalcin expression during bone repair in rats. 2012 Ultrasonics pmid:21820693
Bergström I et al. Physical training increases osteoprotegerin in postmenopausal women. 2012 J. Bone Miner. Metab. pmid:21823052
Nanda KS et al. Elevated circulating osteoprotegerin and reduced matrix-metalloprotease-9 in post-menopausal women with chronic Hepatitis C virus infection. 2012 Cytokine pmid:22863720
Dickerson TJ et al. Rheumatoid and pyrophosphate arthritis synovial fibroblasts induce osteoclastogenesis independently of RANKL, TNF and IL-6. 2012 J. Autoimmun. pmid:22867712
Chao TH et al. Opposite associations of osteoprotegerin and ZBTB40 polymorphisms with bone mineral density of the hip in postmenopausal Taiwanese women. 2012 J Chin Med Assoc pmid:22824048
Wang Y et al. Inhibitory effect of adenovirus-mediated siRNA-targeting BMPR-IB on UHMWPE-induced bone destruction in the murine air pouch model. 2012 Connect. Tissue Res. pmid:22827452
Zhang L et al. Effect of heat stress on the expression levels of receptor activator of NF-κB ligand and osteoprotegerin in human periodontal ligament cells. 2012 Int Endod J pmid:21899569
Zhou WJ et al. [Expression of receptor activator of NF-κB ligand and osteoprotegerin in peri-implant tissues during unloading period]. 2012 Zhonghua Kou Qiang Yi Xue Za Zhi pmid:22883830
Mayahara K et al. Osteoblasts stimulate osteoclastogenesis via RANKL expression more strongly than periodontal ligament cells do in response to PGE(2). 2012 Arch. Oral Biol. pmid:22884709
Hosbond SE et al. Osteoprotegerin as a marker of atherosclerosis: a systematic update. 2012 Scand. Cardiovasc. J. pmid:22506827
Taddei SR et al. Role of CCR2 in orthodontic tooth movement. 2012 Am J Orthod Dentofacial Orthop pmid:22284282
Karieb S and Fox SW Zinc modifies the effect of phyto-oestrogens on osteoblast and osteoclast differentiation in vitro. 2012 Br. J. Nutr. pmid:22289672
Campia U et al. Osteoprotegerin and outcomes in acute coronary syndromes--when the culprit is not the plaque. 2012 Heart pmid:22543836
Choe WS et al. Association between OPG, RANK and RANKL gene polymorphisms and susceptibility to acute coronary syndrome in Korean population. 2012 J. Genet. pmid:22546829
Bloch SL et al. The viability of perilabyrinthine osteocytes: a quantitative study using bulk-stained undecalcified human temporal bones. 2012 Anat Rec (Hoboken) pmid:22577084
Tsubaki M et al. Bisphosphonate- and statin-induced enhancement of OPG expression and inhibition of CD9, M-CSF, and RANKL expressions via inhibition of the Ras/MEK/ERK pathway and activation of p38MAPK in mouse bone marrow stromal cell line ST2. 2012 Mol. Cell. Endocrinol. pmid:22579611
Wang YD et al. Dehydroepiandrosterone indirectly inhibits human osteoclastic resorption via activating osteoblastic viability by the MAPK pathway. 2012 Chin. Med. J. pmid:22613593
Ma Y et al. Effects of brucine on bone metabolism in multiple myeloma. 2012 Mol Med Rep pmid:22614932
Ma D et al. Smoke-induced signal molecules in bone marrow cells from altered low-density lipoprotein receptor-related protein 5 mice. 2012 J. Proteome Res. pmid:22616666
Kim EC et al. Lysyl oxidase and the lysyl oxidase-like protein modulate odontoblastic differentiation of human dental pulp cells. 2012 J Endod pmid:22595110
da Silva RA et al. Toll-like receptor 2 knockout mice showed increased periapical lesion size and osteoclast number. 2012 J Endod pmid:22595116
Chen WH et al. Effects of huogu I formula (I) on correlated factors of bone regeneration in chickens with steroid-induced necrosis of femoral head. 2012 Chin J Integr Med pmid:22549392
Lee JW et al. Coptisine inhibits RANKL-induced NF-κB phosphorylation in osteoclast precursors and suppresses function through the regulation of RANKL and OPG gene expression in osteoblastic cells. 2012 J Nat Med pmid:21656335
Canon J et al. RANKL inhibition combined with tamoxifen treatment increases anti-tumor efficacy and prevents tumor-induced bone destruction in an estrogen receptor-positive breast cancer bone metastasis model. 2012 Breast Cancer Res. Treat. pmid:22926264
Shuid AN et al. Eurycoma longifolia upregulates osteoprotegerin gene expression in androgen- deficient osteoporosis rat model. 2012 BMC Complement Altern Med pmid:22967165
Fichna M et al. Increased serum osteoprotegerin in patients with primary adrenal insufficiency receiving conventional hydrocortisone substitution. 2012 J. Physiol. Pharmacol. pmid:23388484
Sanchez C et al. Regulation of subchondral bone osteoblast metabolism by cyclic compression. 2012 Arthritis Rheum. pmid:22034083
Torchinsky A et al. Bone loss in adult offspring induced by low-dose exposure to teratogens. 2012 J. Bone Miner. Metab. pmid:21960178
Schweikle E et al. Osteoprotegerin positively regulates hematopoietic progenitor cells. 2012 Curr Stem Cell Res Ther pmid:22023625
García-Martín A et al. [Effect of milk product with soy isoflavones on quality of life and bone metabolism in postmenopausal Spanish women: randomized trial]. 2012 Med Clin (Barc) pmid:22024564
Zijlstra WP et al. Cobalt and chromium ions reduce human osteoblast-like cell activity in vitro, reduce the OPG to RANKL ratio, and induce oxidative stress. 2012 J. Orthop. Res. pmid:22025323
Fitzgerald O and Chandran V Update on biomarkers in psoriatic arthritis: a report from the GRAPPA 2010 annual meeting. 2012 J. Rheumatol. pmid:22298273
Silva JA et al. Periodontal disease-associated compensatory expression of osteoprotegerin is lost in type 1 diabetes mellitus and correlates with alveolar bone destruction by regulating osteoclastogenesis. 2012 Cells Tissues Organs (Print) pmid:22301390
Gradosova I et al. Protective effect of amlodipine on rat bone tissue after orchidectomy. 2012 Pharmacology pmid:22302040
Kennedy OD et al. Activation of resorption in fatigue-loaded bone involves both apoptosis and active pro-osteoclastogenic signaling by distinct osteocyte populations. 2012 Bone pmid:22342796
Leistner DM et al. Elevated levels of the mediator of catabolic bone remodeling RANKL in the bone marrow environment link chronic heart failure with osteoporosis. 2012 Circ Heart Fail pmid:22936827
Liu T et al. [Correlation between local microenvironment leptin expression and avascular necrosis of the femoral head]. 2012 Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi pmid:23230665
Li L et al. [Progress of osteogenic effect of strontium and its application in orthopaedics]. 2012 Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi pmid:23230680
Qiu S et al. [Design and activity verification of human parathyroid hormone (1-34) mutant protein]. 2012 Yao Xue Xue Bao pmid:22993856
Vik A et al. Serum osteoprotegerin and future risk of venous thromboembolism. The Tromsø study. 2012 Thromb. Res. pmid:22909822
Dong W et al. [Effect of alendronate on expressions of osteoprotegerin and receptor activator of nuclear factor κB ligand in mouse osteoblasts]. 2012 Nan Fang Yi Ke Da Xue Xue Bao pmid:23268391
Feng Y et al. AMP-activated protein kinase acts as a negative regulator of high glucose-induced RANKL expression in human periodontal ligament cells. 2012 Chin. Med. J. pmid:22964327
Pedersen S et al. Osteoprotegerin predicts long-term outcome in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. 2012 Cardiology pmid:22964478
Mlakar SJ et al. Testing GSTP1 genotypes and haplotypes interactions in Slovenian post-/pre-menopausal women: novel involvement of glutathione S-transferases in bone remodeling process. 2012 Maturitas pmid:22221655
Kadkhodazadeh M et al. Analysis of osteoprotegerin (OPG) gene polymorphism in Iranian patients with chronic periodontitis and peri-implantitis. A cross-sectional study. 2012 Eur J Oral Implantol pmid:23304691
Curl L et al. A pharmacodynamic investigation into the efficacy of osteoprotegerin during aseptic inflammation. 2012 Aust Orthod J pmid:23304971
Emanuele E et al. Linking atherosclerosis to Alzheimer's disease: focus on biomarkers. 2012 Front Biosci (Elite Ed) pmid:22201906
Karatolios K et al. Osteoprotegerin (OPG) and TNF-related apoptosis-inducing ligand (TRAIL) levels in malignant and benign pericardial effusions. 2012 Clin. Biochem. pmid:22202560
Delgado-Calle J et al. Role of DNA methylation in the regulation of the RANKL-OPG system in human bone. 2012 Epigenetics pmid:22207352
Bao L et al. Adeno-associated virus-mediated osteoprotegerin gene transfer protects against joint destruction in a collagen-induced arthritis rat model. 2012 Joint Bone Spine pmid:22154615
Shahnazari M et al. Bone turnover markers in peripheral blood and marrow plasma reflect trabecular bone loss but not endocortical expansion in aging mice. 2012 Bone pmid:22154841
Zheng CM et al. Association between increased serum osteoprotegerin levels and improvement in bone mineral density after parathyroidectomy in hemodialysis patients. 2012 Tohoku J. Exp. Med. pmid:22156488
Said F et al. The effect of etidronate on the periodontium of ovariectomized rats. 2012 J. Periodontol. pmid:22166164
Guo D et al. Bone morphogenetic protein 4 (BMP4) is required for migration and invasion of breast cancer. 2012 Mol. Cell. Biochem. pmid:22167620
Svensson M et al. Osteoprotegerin as a predictor of renal and cardiovascular outcomes in renal transplant recipients: follow-up data from the ALERT study. 2012 Nephrol. Dial. Transplant. pmid:22172725
Çanga A et al. Elevated serum osteoprotegerin levels predict in-hospital major adverse cardiac events in patients with ST elevation myocardial infarction. 2012 J Cardiol pmid:22727437
Yoon WJ et al. Sargachromanol G regulates the expression of osteoclastogenic factors in human osteoblast-like MG-63 cells. 2012 Food Chem. Toxicol. pmid:22727857
Miyaji Y et al. Novel comb-shaped PEG modification enhances the osteoclastic inhibitory effect and bone delivery of osteoprotegerin after intravenous administration in ovariectomized rats. 2012 Pharm. Res. pmid:22729371
Khoury N et al. Resorptive hypercalcemia in post-essential thrombocythemia myelofibrosis: treatment with denosumab. 2012 J. Clin. Endocrinol. Metab. pmid:22730513
Oue E et al. CXCL2 synthesized by oral squamous cell carcinoma is involved in cancer-associated bone destruction. 2012 Biochem. Biophys. Res. Commun. pmid:22771802
Bilgin E et al. Markers of bone metastases in breast and lung cancers. 2012 Asian Pac. J. Cancer Prev. pmid:23167338
Luo ZR and Xie QJ [Correlation between osteoprotegerin gene 209G/A, 245T/G and 1181G/C polymorphism and acute coronary syndromes in Han people of Fujian area]. 2012 Zhongguo Wei Zhong Bing Ji Jiu Yi Xue pmid:23168201
Cui L et al. Effect of fluid flow-induced shear stress on osteoclast formation induced by osteocyte. 2012 Zhongguo Yi Xue Ke Xue Yuan Xue Bao pmid:22776650
Li YL and Wang H [Serum osteoprotegerin level in children with nephrotic syndrome and the effect of glucocorticoid on it]. 2012 Zhongguo Dang Dai Er Ke Za Zhi pmid:22989431
Tyagi AM et al. Formononetin reverses established osteopenia in adult ovariectomized rats. 2012 Menopause pmid:22781783
Xu Y et al. [The function of bushen qiangdu recipe containing serum in OPG/RANKL pathway of ankylosing spondylitis patients]. 2012 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:22803436
Zhu XF et al. [Effects of yigu capsule containing serum on the osteoblast differentiation and the expressions of osteoprotegerin and bone morphogenetic protein 2 after treatment by advanced glycation end products in vitro]. 2012 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:22803437
Histing T et al. Melatonin impairs fracture healing by suppressing RANKL-mediated bone remodeling. 2012 J. Surg. Res. pmid:20888595
Liu L et al. [Effect of gradually induced disordered occlusion on the expression of osteoprotegerin and receptor activator of nuclear factor-kappaB ligand in mandibular condylar cartilage of rats]. 2012 Hua Xi Kou Qiang Yi Xue Za Zhi pmid:22594224
Zhou W et al. [Expression of receptor activator nuclear factor kappa B ligand and osteoprotegerin in peri-implant soft tissue and bone tissue]. 2012 Hua Xi Kou Qiang Yi Xue Za Zhi pmid:22389960

Table of Content